CSW Industrials Reports Q2 2027 Earnings Beat with Record Adjusted EBITDA
CSW Industrials (NYSE: CSW) reported second-quarter fiscal 2027 results that exceeded market expectations on both the top and bottom lines. The company posted a Non-GAAP EPS of $3.66, beating estimates by $0.03, while revenue reached $361 million, surpassing projections by $10.03 million. Financial strength was highlighted by a 33% increase in adjusted EBITDA to a record $97 million and an increase in net income to $47.3 million from $40.7 million in the prior year period. Despite these strong results, management cautioned that recent cost increases could create short-term margin headwinds. The company maintained its full-year fiscal 2027 outlook, expressing confidence in sustained organic revenue growth that continues to outpace the markets it serves.
Coverage
- Sally Beauty Reports Q4 Earnings Beat and Provides FY27 Guidance
- TransDigm Group Reports Q4 Earnings Beat and Issues Fiscal 2027 Guidance
- Foghorn Therapeutics GAAP EPS of $0.80, revenue of $83.5M
- RB Global Non-GAAP EPS of $1.03 beats by $0.03, revenue of $1.3B beats by $130M
- ADC Therapeutics Non-GAAP EPS of -$0.06, revenue of $21M beats by $1.93M
- Praxis Precision Medicines Non-GAAP EPS of -$3.23 beats by $0.40
- Editas Medicine GAAP EPS of -$0.15 beats by $0.04, revenue of $10.37M beats by $5.84M
- Atmus Filtration Non-GAAP EPS of $0.77 beats by $0.04, revenue of $510M beats by $8.47M
- inTest Corporation Reports Q3 Earnings Beat Driven by Record Semiconductor Orders
- Humana Non-GAAP EPS of -$0.70 beats by $0.30, revenue of $41.16B beats by $270M
- Live Nation Entertainment GAAP EPS of $1.69 beats by $0.19, revenue of $10.1B beats by $520M
- SoundHound AI Reports Q3 Revenue Beat and Significant Cost Synergy Targets
- MP Materials Non-GAAP EPS of $0.04 beats by $0.05, revenue of $147.6M beats by $28.74M
- Halozyme Therapeutics Non-GAAP EPS of $2.39 beats by $0.03, revenue of $493M beats by $1.44M
- RALPH LAUREN CORP - 8-K Filing
- Parker-Hannifin Reports Q1 Earnings Beat and Updates Fiscal Year Guidance
- Cummins Reports Third Quarter Results with Revenue and EPS Misses
- Apyx Medical Reports Q3 Earnings Beat and Reaffirms FY26 Outlook
- Sun Life Financial Non-GAAP EPS of C$2.05 beats by C$0.04
- JACK HENRY & ASSOCIATES INC - 8-K Filing
- Fabrinet Reports Q1 Earnings Beat with $1.47 Billion in Revenue
- Clorox Reports Q1 Earnings Beat Driven by Strong Revenue Growth and GOJO Acquisition
- RBC Bearings Reports Q2 Fiscal 2027 Results with Earnings and Revenue Beats
- Ranpak Holdings Reports Q3 Earnings Miss on Both Top and Bottom Lines
- CSW Industrials Reports Q2 2027 Earnings Beat with Record Adjusted EBITDA